Ishita Drugs & Industries' Stock Reaches 52-Week High, Outperforms Sector by 8.51%
Ishita Drugs & Industries, a microcap pharmaceutical company, has been making waves in the stock market with its share price reaching a 52-week high on February 2, 2024. The stock has been outperforming its sector by 8.51% and has shown a consecutive upward trend, gaining 26.8% in the last two days. Its strong presence in the industry and consistent efforts towards innovation have contributed to its remarkable growth of 85.27% in the past year.
Ishita Drugs & Industries, a microcap pharmaceutical company, has been making headlines in the stock market as its share price reached a 52-week high on February 2, 2024. The stock, which is currently trading at Rs. 90.9, has been performing well in the market, outperforming its sector by 8.51%.
In the last two days, the stock has gained 26.8%, showcasing a consecutive upward trend. Today, the stock opened with a gain of 4.83% and touched an intraday high of Rs. 90.9, which is a 10.88% increase from its previous close. However, it also saw some volatility, with an intraday low of Rs. 76.11, a decrease of 7.16%.
Ishita Drugs & Industries is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its performance. In the past year, the company has shown a remarkable growth of 85.27%, while the Sensex has only grown by 21.54%.
This impressive performance of Ishita Drugs & Industries can be attributed to its strong presence in the pharmaceutical industry and its consistent efforts towards innovation and growth. As a microcap company, it has shown great potential and is definitely one to watch in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
